Program

Session 4 ‘Innovative approaches for treatment of IE’

-
  • 11h-11h30: Percutaneous mechanical aspiration (Abdallah El Sabbagh, USA)
  • 11h30-12h: Breakthroughs in cardiac surgery (Carlos Mestres, Switzerland)
  • 12h-12h30: Lysins & phages as salvage treatment for complicated bacteremia and IE (Tristan Ferry, France)
  • 12h30-13h: Presentations selected from abstract submission

 

  • Continuous administration of high-dose intravenous amoxicillin as a strategy for preventing crystalline nephropathy in Streptococcal or Enterococcal endocarditis therapy – a multicentric cohort study with propensity score matching - Camille Gand, Tours, France
  • Characteristics and outcomes of Operated versus non-Operated Patients with infective Endocarditis and ceRebral complications: the COOPER study - Julien Ternacle, Pessac, France
  • Sex Differences in Clinical Profile and Outcomes of Surgically Treated Left-Sided Infective Endocarditis: Results from the International, Prospective, Multicenter BESOS (Barcelona Endocarditis Surgery Outcome Score) Study - Núria Fernández-Hidalgo, Barcelona, Spain

Back to program

Shionogi
Pfizer
Menarini